PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 9, 2024Neurology5 citations

Phase 1 Study Evaluating the Safety and Tolerability of BHV-7000, a Novel, Selective Kv7.2/7.3 Potassium Channel Activator, in Healthy Adults (P8-1.007)

View Full Paper
BABharat AwsareJLJason T. LernerEAEric Ashbrenner

Key Points

Key points are not available for this paper at this time.

Abstract

Evaluate the safety and tolerability of single and multiple ascending doses (SAD and MAD) of oral BHV-7000.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Awsare et al. (2024) studied this question.

synapsesocial.com/papers/68e6fca8b6db643587676879https://doi.org/10.1212/wnl.0000000000206409
Ask AI
Helpful
Bookmark
Share
View Full Paper